| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |